What's behind Kodak's pivot to pharmaceuticals?

Last month, the U.S. government announced a letter of interest to provide Kodak with a $765 million loan to manufacture pharmaceutical ingredients. The deal is now on hold as the SEC investigates the circumstances around the loan's disclosure.